Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Interference01:23

RNA Interference

28.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.5K
CRISPR01:59

CRISPR

58.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.8K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

2.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.5K
Experimental RNAi02:15

Experimental RNAi

8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
Homologous Recombination02:31

Homologous Recombination

65.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SNIPSNP: precision design of CRISPR/Cas9 knock-in reagents for variant correction and disease modeling.

Nucleic acids research·2026
Same author

Disinhibition of cerebellar output by loss of restless legs syndrome-associated gene MEIS1.

Current biology : CB·2026
Same author

Expanding the human proteome with microproteins and peptideins.

Nature·2026
Same author

A non-invasive method to genotype cephalopod sex by quantitative PCR.

iScience·2026
Same author

Nature-inspired neuroscience.

Current opinion in neurobiology·2026
Same author

Protocol for genotyping cephalopod sex using a skin swab and quantitative PCR.

bioRxiv : the preprint server for biology·2026
Same journal

Large-scale discovery and annotation of substructure patterns in mass spectrometry profiles.

Nature communications·2026
Same journal

Salmonella SopB suppresses post-transcriptionally regulated cytokine release to reduce early tissue inflammation and delay disease progression.

Nature communications·2026
Same journal

A human-specific microRNA controls the timing of excitatory synaptogenesis.

Nature communications·2026
Same journal

An HMA-like integrated domain in the wheat tandem kinase WTK4 recognises an RNase-like pathogen effector.

Nature communications·2026
Same journal

Learning regularities in noise engages both neural predictive activity and representational changes.

Nature communications·2026
Same journal

The H3K4 methyltransferase KMT2D is an essential cofactor for GATA1 at erythroid gene enhancers.

Nature communications·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

36.2K

Internal guide RNA interactions interfere with Cas9-mediated cleavage.

Summer B Thyme1, Laila Akhmetova1, Tessa G Montague1

  • 1Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, BIOL 1020, Cambridge, Massachusetts 02138, USA.

Nature Communications
|June 11, 2016
PubMed
Summary
This summary is machine-generated.

Guide RNAs (gRNAs) in CRISPR/Cas systems can fail to function due to internal structures or genomic inhibitors like CTCF, impacting DNA editing efficiency. Understanding these factors is key to improving CRISPR technology.

More Related Videos

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
11:27

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Published on: August 28, 2018

23.2K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.7K

Related Experiment Videos

Last Updated: Mar 19, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

36.2K
Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
11:27

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Published on: August 28, 2018

23.2K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.7K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies
  • Biochemistry

Background:

  • The CRISPR/Cas system relies on guide RNAs (gRNAs) to direct Cas9 enzyme for sequence-specific DNA cleavage.
  • The precise mechanisms governing gRNA efficiency and Cas9 activity remain incompletely understood.
  • Low CRISPR/Cas editing efficiency can stem from issues in forming functional Cas9-gRNA complexes or target recognition in vivo.

Purpose of the Study:

  • To investigate the factors limiting gRNA activity in CRISPR/Cas systems.
  • To differentiate between in vitro and in vivo influences on Cas9-gRNA complex function.
  • To elucidate the roles of genomic context and gRNA secondary structures in modulating Cas9 activity.

Main Methods:

  • Comparative analysis of mutagenesis rates in zebrafish embryos and in vitro DNA cleavage assays.
  • Utilizing near-identical gRNA sequences with varying in vitro cleavage efficiencies.
  • Investigating the impact of genomic factors, such as CTCF, on CRISPR-mediated mutagenesis.

Main Results:

  • Genomic factors, exemplified by CTCF, were identified as inhibitors of in vivo mutagenesis.
  • Internal secondary structures within gRNAs were shown to reduce in vitro DNA cleavage efficiency.
  • gRNAs with internal structures, despite forming non-cleavage-competent complexes, can sequester Cas9, hindering active gRNAs.

Conclusions:

  • Both the genomic environment and internal gRNA structures significantly impede Cas9-mediated DNA cleavage.
  • These findings reveal previously uncharacterized mechanisms affecting Cas9-gRNA complex formation and function.
  • Understanding these inhibitory factors is crucial for optimizing CRISPR/Cas gene editing applications.